Literature DB >> 7656920

Polymorphonuclear leucocyte dysregulation in patients with gram-negative septicaemia assessed by flow cytometry.

C Wenisch1, P Parschalk, M Hasenhündl, A Griesmacher, W Graninger.   

Abstract

Flow cytometry was used to study phagocytic function and release of reactive oxygen intermediates (ROI) following phagocytosis by granulocytes in 14 patients (six female, eight male) with gram-negative septicaemia prior to, during, and after therapy compared with a group of healthy controls. Phagocytic capacity was assessed by measuring uptake of fluorescein isothiocyanate (FITC)-labelled bacteria. Reactive oxygen generation after phagocytosis was measured by the quantification of dihydrorhodamine 123 converted to rhodamine 123 intracellulary. Compared with results in healthy controls granulocytes of septicaemic patients exhibited a decreased capacity to phagocytize Escherichia coli and to generate reactive oxygen products. Both phagocytosis and ROI production increased after initiation of therapy and normalized within 7 days of treatment. The results suggest that granulocytes do not only participate in, but are also a target of, the septic host inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7656920     DOI: 10.1111/j.1365-2362.1995.tb01723.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  2 in total

1.  Effect of pentoxifylline in vitro on neutrophil reactive oxygen production and phagocytic ability assessed by flow cytometry.

Authors:  C Wenisch; K Zedtwitz-Liebenstein; B Parschalk; W Graninger
Journal:  Clin Drug Investig       Date:  1997       Impact factor: 2.859

2.  Bioartificial Therapy of Sepsis: Changes of Norepinephrine-Dosage in Patients and Influence on Dynamic and Cell Based Liver Tests during Extracorporeal Treatments.

Authors:  Martin Sauer; Jens Altrichter; Cristof Haubner; Annette Pertschy; Thomas Wild; Fanny Doß; Thomas Mencke; Maren Thomsen; Johannes Ehler; Jörg Henschel; Sandra Doß; Stephanie Koch; Georg Richter; Gabriele Nöldge-Schomburg; Steffen R Mitzner
Journal:  Biomed Res Int       Date:  2016-06-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.